CRTX insider filings

Cortexyme, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2022-07-01. Screen CRTX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for CRTX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — Cortexyme, Inc.

FiledFormInsiderReported transactionsSource
2022-07-014Monohon Ted — Chief Accounting Officer & VPGrant/award (A): 250,000 (derivative) @ $0EDGAR
2022-06-104Bray June — DirectorGrant/award (A): 54,000 (derivative) @ $0EDGAR
2022-06-094Lamond David — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2022-06-094McLoughlin Margaret — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2022-06-094Senner Christopher J. — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2022-06-094RYAN UNA S — DirectorGrant/award (A): 27,000 (derivative) @ $0EDGAR
2022-06-084Holsinger Leslie — EVP, Preclinical DevelopmentTax withholding (F): 10,920 @ $2.86EDGAR
2022-06-084McDowell Caryn Gordon — Chief Legal & Adm. OfficerTax withholding (F): 6,700 @ $2.86 · Sale (S): 10,800 @ $2.86EDGAR
2022-06-084Monohon Ted — Chief Accounting Officer & VPTax withholding (F): 1,529 @ $3.12EDGAR
2022-05-274/AHannah Brendan — Chief Business OfficerGrant/award (A): 113,569 @ $0EDGAR
2022-05-274/ASmith Karen L. — Chief Medical OfficerGrant/award (A): 170,354 @ $0EDGAR
2022-05-274/AThye Dirk — Chief Executive Officer, DirectorGrant/award (A): 216,322 @ $0EDGAR
2022-05-234Lamond David — DirectorGrant/award (A): 200,002EDGAR
2022-05-234Hannah Brendan — Chief Business OfficerGrant/award (A): 16,224 · Grant/award (A): 103,500 (derivative) · Grant/award (A): 353,656 (derivative) @ $0EDGAR
2022-05-234Smith Karen L. — Chief Medical OfficerGrant/award (A): 24,336 · Grant/award (A): 151,799 (derivative) · Grant/award (A): 1,365,449 (derivative) @ $0EDGAR
2022-05-234Thye Dirk — Chief Executive Officer, DirectorGrant/award (A): 64,589 · Grant/award (A): 206,391 (derivative) · Grant/award (A): 1,979,650 (derivative) @ $0EDGAR
2022-05-234Low Philip S — DirectorGrant/award (A): 455,309 · Grant/award (A): 63,974 · Grant/award (A): 22,058 (derivative) @ $0EDGAR
2022-03-164Sabbagh Marwan — DirectorGrant/award (A): 22,058 (derivative) @ $0EDGAR
2022-03-044McDowell Caryn Gordon — Chief Legal & Adm. OfficerGrant/award (A): 140,000 @ $0EDGAR
2022-03-044Holsinger Leslie — EVP, Preclinical DevelopmentGrant/award (A): 155,500 @ $0EDGAR
2022-03-044Detke Michael J. — Chief Medical OfficerGrant/award (A): 140,000 @ $0EDGAR
2022-03-044Monohon Ted — Chief Accounting Officer & VPGrant/award (A): 34,000 @ $0EDGAR
2022-03-044LOWE CHRISTOPHER P. — Interim CEO, COO & CFOGrant/award (A): 175,000 @ $0EDGAR
2022-01-054Lynch Casey — Chief Executive Officer, DirectorGrant/award (A): 440,000 (derivative) @ $0EDGAR
2022-01-054McDowell Caryn Gordon — Chief Legal & Adm. OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-054Holsinger Leslie — EVP, R&DGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-054Dominy Stephen S. — Chief Scientific Officer, DirectorGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-054Detke Michael J. — Chief Medical OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2022-01-054Monohon Ted — Chief Accounting OfficerGrant/award (A): 50,000 (derivative) @ $0EDGAR
2022-01-054LOWE CHRISTOPHER P. — COO & Chief Financial OfficerGrant/award (A): 125,000 (derivative) @ $0EDGAR
2021-11-194Lynch Casey — Chief Executive Officer, DirectorOption exercise (M): 60,000 @ $0.46 · Option exercise (M): 60,000 (derivative) @ $0EDGAR
2021-11-164LOWE CHRISTOPHER P. — COO & Chief Financial OfficerOption exercise (M): 30,000 @ $2.23 · Option exercise (M): 30,000 (derivative) @ $0EDGAR
2021-11-124Dominy Stephen S. — Chief Scientific Officer, DirectorPurchase (P): 763 @ $14.40EDGAR
2021-10-124McLoughlin Margaret — DirectorOption exercise (M): 1,000 @ $17 · Sale (S): 1,000 @ $88.93 · Option exercise (M): 1,000 (derivative) @ $0EDGAR
2021-10-074LOWE CHRISTOPHER P. — COO & Chief Financial OfficerOption exercise (M): 4,963 @ $54.85 · Sale (S): 4,963 @ $98.50 · Option exercise (M): 4,963 (derivative) @ $0EDGAR
2021-08-184McLoughlin Margaret — DirectorOption exercise (M): 6,000 @ $17 · Sale (S): 3,056 @ $94.55 · Sale (S): 1,044 @ $95.57 · Sale (S): 1,429 @ $96.51 · Sale (S): 423 @ $97.55 · Sale (S): 48 @ $98.90 · +1 moreEDGAR
2021-08-184LOWE CHRISTOPHER P. — COO & Chief Financial OfficerOption exercise (M): 22,000 @ $2.23 · Sale (S): 9,158 @ $94.23 · Sale (S): 7,335 @ $95.02 · Sale (S): 2,330 @ $96.32 · Sale (S): 1,100 @ $97.28 · Sale (S): 2,077 @ $98.90 · +3 moreEDGAR
2021-08-124Detke Michael J. — Chief Medical OfficerOption exercise (M): 10,000 @ $2.23 · Sale (S): 10,000 @ $100 · Option exercise (M): 10,000 (derivative) @ $0EDGAR
2021-07-074Detke Michael J. — Chief Medical OfficerOption exercise (M): 12,600 @ $2.23 · Sale (S): 32,313 @ $53.43 · Sale (S): 8,260 @ $53.91 · Sale (S): 288 @ $55.01 · Option exercise (M): 17,400 @ $2.23 · Sale (S): 3,934 @ $53.24 · +6 moreEDGAR
2021-06-304LOWE CHRISTOPHER P. — COO & Chief Financial OfficerOption exercise (M): 20,000 @ $2.23 · Sale (S): 7,724 @ $53.39 · Sale (S): 7,079 @ $54.13 · Sale (S): 4,153 @ $55.11 · Sale (S): 1,044 @ $56.16 · Option exercise (M): 30,000 @ $2.23 · +2 moreEDGAR
2021-06-294McLoughlin Margaret — DirectorSale (S): 200 @ $55.01 · Sale (S): 250 @ $55.03 · Sale (S): 100 @ $55.73EDGAR
2021-06-174McLoughlin Margaret — DirectorGrant/award (A): 11,029 (derivative) @ $0EDGAR
2021-06-174Lamond David — DirectorGrant/award (A): 11,029 (derivative) @ $0EDGAR
2021-06-174Senner Christopher J. — DirectorGrant/award (A): 11,029 (derivative) @ $0EDGAR
2021-06-174RYAN UNA S — DirectorGrant/award (A): 11,029 (derivative) @ $0EDGAR
2021-05-124Lynch Casey — Chief Executive Officer, DirectorSale (S): 13,584 @ $33.75 · Sale (S): 9,918 @ $34.89 · Sale (S): 6,315 @ $35.81 · Sale (S): 183 @ $36.73EDGAR
2021-03-244Lamond David — DirectorPurchase (P): 50,000 @ $33.77EDGAR
2021-03-234Lamond David — DirectorGift (G): 1,534,720 @ $0EDGAR
2021-03-234Lynch Casey — Chief Executive Officer, DirectorSale (S): 11,211 @ $35.10 · Sale (S): 18,089 @ $35.85 · Sale (S): 300 @ $36.58 · Sale (S): 400 @ $36.60EDGAR
2021-03-054Lamond David — DirectorPurchase (P): 16,621 @ $34.28 · Purchase (P): 13,310 @ $35 · Purchase (P): 15,969 @ $36.34 · Purchase (P): 4,100 @ $36.86EDGAR

Recent 8-K events — Cortexyme, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2026-11-138-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-198-K7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-098-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-068-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2026-10-028-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-09-148-K2.01 — Completion of Acquisition or Disposition of Assets
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
9.01 — Financial Statements and Exhibits
EDGAR
2026-09-048-K3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of ListingEDGAR
2026-08-278-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2026-08-178-K8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2026-08-148-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=CRTX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs